We explore how a 27‑billion-parameter biology foundation model from the Gemma family generated a testable, context‑dependent hypothesis that boosts MHCI antigen presentation only under a specific immune condition. Through a dual‑context virtual screen, somatassertib (CX4945) was predicted to act as a conditional amplifier and validated experimentally in human neuroendocrine cells, marking a milestone in AI‑driven biology. We discuss the implications for cancer immunotherapy, the future of AI‑assisted discovery, and where to access the preprint, model, and code.
Note: This podcast was AI-generated, and sometimes AI can make mistakes. Please double-check any critical information.
Sponsored by Embersilk LLC
Fler avsnitt av Intellectually Curious
Visa alla avsnitt av Intellectually CuriousIntellectually Curious med Mike Breault finns tillgänglig på flera plattformar. Informationen på denna sida kommer från offentliga podd-flöden.